health π₯ Medical supplies markup is too high, says FDA official
An IV set costing Rs 11 was reportedly sold for Rs 325, showing massive profit margins across hospital consumables. This finding came from a market survey conducted by the Maharashtra State Price Monitoring Resource Unit under the state Food and Drugs Administration. The survey revealed mark-ups of up to 29 times the procurement cost on essential inpatient medical devices. Maharashtra FDA Commissioner Tukaram Mundhe called this pricing irrational and urged the Centre to intervene. He proposed placing these consumables under the Drugs (Prices Control) Order (DPCO), 2013 for regulation.